Table 1.
The impact of different factors on VISTA H-score (protein) level. Clinical characteristics of the 71-patient group with H-score.
| Clinical Factor | p | |||||
|---|---|---|---|---|---|---|
| N (%) | ||||||
| Sex | Female | 22 (31.0) | 0.7 | |||
| Male | 49 (69.0) | |||||
| Median (range) | ||||||
| Age | 60 (30–90) | 0.99 | ||||
| 0 = no, 1 = yes (%), NA = not available | ||||||
| Radiotherapy | 0: 32 (45.1) | 1: 36 (50.7) | NA: 2 (2.8) | 0.72 | ||
| Chemotherapy | 0: 62 (87.3) | 1: 6 (8.5) | NA: 2 (2.8) | 0.25 | ||
| Surgical resection | 0: 16 (22.5) | 1: 55 (77.5) | 0.07 | |||
| (1–3):N(%) | ||||||
| Grade | 1: 32 (45.1) | 2: 32 (45.1) | 3: 7 (9.9) | 0.51 | ||
| (1–4):N(%) | ||||||
| AJCC Stage | 1: 17 (23.9) | 2: 15 (21.1) | 3: 12 (16.9) | 4: 27 (38.0) | 0.66 | |
| T (1–4):N(%), N (0–3):N(%) | ||||||
| Classification | T | 1: 12 (16.9) | 2: 26 (36.6) | 3: 14 (19.7) | 4: 19 (26.8) | 0.86 |
| N | 0: 29 (40.8) | 1: 13 (18.3) | 2: 25 (35.2) | 3: 4 (5.6) | 0.82 | |
For the group of patients, p-value was estimated to find any significant difference in VISTA expression level according to Grade, AJCC Stage, T and N classifications with the Kruskal–Wallis one-way ANOVA test, and according to other parameters with the Mann–Whitney U test.